Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Vapendavir

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Altesa BioSciences Shares Phase 2 Vapendavir Data at ASM 2026
    Altesa BioSciences Shares Phase 2 Vapendavir Data at ASM 2026

    05 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/altesa-biosciences-presents-new-phase-2-vapendavir-challenge-study-results-at-2026-american-society-for-microbiology-asm-microbe-conference-302792177.html

    PR NEWSWIRE
    05 Jun 2026
    Share Share
    Altesa Bio Appoints Board Member and SVP of Clinical Development
    Altesa Bio Appoints Board Member and SVP of Clinical Development

    02 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/altesa-biosciences-appoints-brett-haumann-mbbch-mba-to-its-board-of-directors-and-gwen-skloot-md-atsf-as-senior-vice-president-for-clinical-development-302787752.html

    PR NEWSWIRE
    02 Jun 2026
    Share Share
    Altesa BioSciences: Positive Phase 2 Data for Vapendavir
    Altesa BioSciences: Positive Phase 2 Data for Vapendavir

    19 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/altesa-biosciences-presents-positive-phase-2-challenge-study-results-for-vapendavir-at-american-thoracic-society-international-conference-2026-302776637.html

    PR NEWSWIRE
    19 May 2026
    Share Share
    Altesa BioSciences' Vapendavir Targets All 3 Rhinovirus Species
    Altesa BioSciences' Vapendavir Targets All 3 Rhinovirus Species

    12 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-altesa-biosciences-data-vapendavir-demonstrates-anti-viral-activity-against-all-three-rhinovirus-species-302769111.html

    PR NEWSWIRE
    12 May 2026
    Share Share
    Altesa Enrolls First Patient in Phase 2b CARDINAL COPD Trial
    Altesa Enrolls First Patient in Phase 2b CARDINAL COPD Trial

    05 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/altesa-biosciences-enrolls-first-patient-in-phase-2b-cardinal-clinical-trial-evaluating-vapendavir-as-transformational-treatment-for-patients-with-copd-impacted-by-rhinovirus-the-leading-cause-of-exacerbations-302762079.html

    PR NEWSWIRE
    05 May 2026
    Share Share
    Altesa BioSciences Delivers Oral Presentation at ATS 2026
    Altesa BioSciences Delivers Oral Presentation at ATS 2026

    30 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/altesa-biosciences-selected-for-oral-presentation-at-the-american-thoracic-society-2026-international-congress-302758236.html

    PR NEWSWIRE
    30 Apr 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.